Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma
Details
Publication Year 2023-04-01,Volume 41,Issue #10,Page 1949-1951
Journal Title
Journal of Clinical Oncology
Publication Type
Commentary
Publisher
American Society of Clinical Oncology
Keywords
Humans; *Multiple Myeloma/therapy; *Antibodies, Bispecific/adverse effects; Cell Line, Tumor
Department(s)
Infectious Diseases
PubMed ID
36716411
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-08-07 07:16:15
Last Modified: 2023-08-07 07:17:40

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙